- Report
- June 2023
- 112 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- June 2023
- 115 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- December 2022
- 116 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- March 2025
- 85 Pages
Saudi Arabia
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- January 2025
- 85 Pages
India
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- January 2025
- 80 Pages
India
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- December 2024
- 80 Pages
India
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- September 2024
- 82 Pages
Japan
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- September 2024
- 82 Pages
Japan
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- September 2024
- 80 Pages
Japan
From €2634EUR$2,975USD£2,281GBP
€3099EUR$3,500USD£2,684GBP
- Report
- July 2024
- 183 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- May 2024
- 185 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- April 2024
- 190 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- April 2024
- 180 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- January 2024
- 182 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- October 2023
- 181 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- October 2023
- 180 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- August 2023
- 102 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- July 2024
- 231 Pages
Global
From €7038EUR$7,950USD£6,096GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3320EUR$3,750USD£2,875GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more